Dennis D. Kim

Insider Reports History

Entity
Individual
Location
C/O Emerald Bioscience, Inc., 130 North Marina Drive, Long Beach, CA
Signature
/s/ Paul Quinlan, as attorney-in-fact for Dennis D. Kim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dennis D. Kim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CymaBay Therapeutics, Inc. Chief Medical Officer Common Stock 20K $474K $23.68 Apr 17, 2023 Direct
CymaBay Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 170K Apr 17, 2023 Direct

Insider Reports Filed by Dennis D. Kim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CBAY CymaBay Therapeutics, Inc. Apr 13, 2023 6 -$616K 4 Apr 17, 2023 Chief Medical Officer
CBAY CymaBay Therapeutics, Inc. Mar 28, 2023 3 -$462 4 Mar 30, 2023 Chief Medical Officer
CBAY CymaBay Therapeutics, Inc. Jan 25, 2023 1 $0 4 Jan 27, 2023 Chief Medical Officer
CBAY CymaBay Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 Chief Medical Officer
CBAY CymaBay Therapeutics, Inc. Jan 19, 2022 1 $60.8K 4 Jan 20, 2022 Chief Medical Officer
CBAY CymaBay Therapeutics, Inc. May 17, 2021 2 $0 4 May 17, 2021 Chief Medical Officer
CBAY CymaBay Therapeutics, Inc. May 17, 2021 0 $0 3 May 17, 2021 Chief Medical Officer